中文

Hong Kong Stocks · Free Data Page

ZAI LAB 09688

ZAI LAB: FY2025 revenue $460.2M (+15.30% YoY); net income -$175.5M; 2 alerts, 2 watch items out of 17 risk checks; no TTM dividend.
Close PriceHK$18.01Day +6.76%Market CapHK$22.53BP/E—Negative earningsP/B4.73xROE (FY2025)-22.6%Avg. equity

Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for ZAI LAB?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2018–2025

Financial statements are reported in USD, while share price and market cap are quoted in HKD.

Key Multi-Year Facts

  • Revenue moved from $129000 in FY2018 to $460.2M in FY2025 (7-year CAGR +221.7%).
  • Net income was negative in FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024, FY2025.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (USD B)0.140.220.270.400.46
YoY194.8%49.0%24.0%49.6%15.3%
Net Income (USD B)-0.70-0.44-0.33-0.26-0.18
Operating Cash Flow (USD B)-3.50-2.56-1.40-1.54-1.06
ROE-55.3%-36.6%-36.3%-31.4%-22.6%
Gross Margin63.8%65.6%64.1%62.9%58.5%
Net Margin-488.2%-206.1%-125.5%-64.4%-38.1%
Debt-to-Assets14.3%14.3%23.2%29.1%39.0%
Show all 8 fiscal years
Fiscal Year20182019202020212022202320242025
Revenue (USD B)0.000.010.050.140.220.270.400.46
YoY—9965.9%277.0%194.8%49.0%24.0%49.6%15.3%
Net Income (USD B)-0.14-0.20-0.27-0.70-0.44-0.33-0.26-0.18
Operating Cash Flow (USD B)-0.67-1.33-1.41-3.50-2.56-1.40-1.54-1.06
ROE-55.4%-71.5%-36.7%-55.3%-36.6%-36.3%-31.4%-22.6%
Gross Margin66.7%71.1%65.8%63.8%65.6%64.1%62.9%58.5%
Net Margin-107810.1%-1502.3%-549.3%-488.2%-206.1%-125.5%-64.4%-38.1%
Debt-to-Assets16.9%17.0%9.9%14.3%14.3%23.2%29.1%39.0%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-05

Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).

2Alert 2Watch 11Pass 2N/A

Items Flagged for Review

  • Alert

    Interest CoverageSolvency

    Negative (negative EBIT)

    FY2025 (ended 2025-12-31) · What is this?

  • Alert

    Net LossesGoing Concern

    FY2025 (2025-12-31) $-0.18B, FY2024 (2024-12-31) $-0.26B

    FY2025 (ended 2025-12-31)

  • Watch

    Inventory DaysFinancial Quality

    142.8 days, prior FY 98.4 days(+45%)

    FY2025 (ended 2025-12-31) · What is this?

  • Watch

    High Cash & High DebtSolvency

    cash 56.5% of assets, total debt 22.2% of assets

    Interim (2026-06-30)

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

Dividends

No dividends paid over the trailing 12 months.

Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.

More data: All research reports · Sector leaders · Market hours & holidays.

Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.